NovoCure Ltd (NVCR)
17.73
+0.64
(+3.74%)
USD |
NASDAQ |
Nov 22, 16:00
17.72
-0.01
(-0.06%)
After-Hours: 20:00
NovoCure Revenue (Quarterly): 155.10M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 155.10M |
| June 30, 2024 | 150.36M |
| March 31, 2024 | 138.50M |
| December 31, 2023 | 133.78M |
| September 30, 2023 | 127.32M |
| June 30, 2023 | 126.05M |
| March 31, 2023 | 122.18M |
| December 31, 2022 | 128.43M |
| September 30, 2022 | 131.00M |
| June 30, 2022 | 140.87M |
| March 31, 2022 | 137.55M |
| December 31, 2021 | 133.21M |
| September 30, 2021 | 133.61M |
| June 30, 2021 | 133.52M |
| March 31, 2021 | 134.70M |
| December 31, 2020 | 143.95M |
| September 30, 2020 | 132.66M |
| June 30, 2020 | 115.92M |
| March 31, 2020 | 101.83M |
| December 31, 2019 | 99.23M |
| September 30, 2019 | 92.06M |
| Date | Value |
|---|---|
| June 30, 2019 | 86.71M |
| March 31, 2019 | 73.31M |
| December 31, 2018 | 69.67M |
| September 30, 2018 | 64.76M |
| June 30, 2018 | 61.51M |
| March 31, 2018 | 52.12M |
| December 31, 2017 | 53.66M |
| September 30, 2017 | 50.11M |
| June 30, 2017 | 38.38M |
| March 31, 2017 | 34.88M |
| December 31, 2016 | 30.24M |
| September 30, 2016 | 21.67M |
| June 30, 2016 | 17.92M |
| March 31, 2016 | 13.05M |
| December 31, 2015 | 12.38M |
| September 30, 2015 | 8.953M |
| June 30, 2015 | 6.543M |
| March 31, 2015 | 5.208M |
| December 31, 2014 | 3.801M |
| September 30, 2014 | 4.374M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
99.23M
Minimum
Dec 2019
155.10M
Maximum
Sep 2024
130.99M
Average
133.36M
Median
Revenue (Quarterly) Benchmarks
| Abbott Laboratories | 10.64B |
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | 10.35M |
| Xtant Medical Holdings Inc | 27.94M |
| Catheter Precision Inc | 0.096M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -30.57M |
| Total Expenses (Quarterly) | 187.19M |
| EPS Diluted (Quarterly) | -0.28 |
| Enterprise Value | 1.613B |
| Gross Profit Margin (Quarterly) | 77.19% |
| Profit Margin (Quarterly) | -19.71% |
| Earnings Yield | -7.90% |
| Normalized Earnings Yield | -7.896 |